Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 29, 2018 - The FDA announced that signs and symptoms of a life-threatening side effect called differentiation syndrome are not being recognized in patients receiving Idhifa (enasidenib).
Return to publications